Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Downregulation of GNA15 Inhibits Cell Proliferation via P38 MAPK Pathway and Correlates with Prognosis of Adult Acute Myeloid Leukemia With Normal Karyotype. | Front Oncol | 2021 | 34552875 | PubTator, text mining | PubMed |
| Noncoding RNAs in pediatric brain tumors: Molecular functions and pathological implications. | Mol Ther Nucleic Acids | 2021 | 34552822 | PubTator, text mining | PubMed |
| Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia. | Cell Rep | 2021 | 34551306 | PubTator, text mining | PubMed |
| [Prognostic value of KIT and other clonal genetic mutations in core-binding factor acute myeloid leukemia]. | Zhonghua Xue Ye Xue Za Zhi | 2021 | 34547870 | PubTator, text mining | PubMed |
| [Chinese guidelines for the diagnosis and treatment of adult acute myeloid leukemia (not APL) (2021)]. | Zhonghua Xue Ye Xue Za Zhi | 2021 | 34547865 | PubTator, text mining | PubMed |
| Comprehensive Analysis of HDAC Family Identifies HDAC1 as a Prognostic and Immune Infiltration Indicator and HDAC1-Related Signature for Prognosis in Glioma. | Front Mol Biosci | 2021 | 34540896 | PubTator, text mining | PubMed |
| Roles of Histone Deacetylases in Acute Myeloid Leukemia With Fusion Proteins. | Front Oncol | 2021 | 34540702 | PubTator, text mining | PubMed |
| A Phase II Trial of the Double Epigenetic Priming Regimen Including Chidamide and Decitabine for Relapsed/Refractory Acute Myeloid Leukemia. | Front Oncol | 2021 | 34540696 | PubTator, text mining | PubMed |
| MRD negative CR after azacitidine and venetoclax in a young patient with AML, unfit for intensive induction followed by ASCT. | Leuk Res Rep | 2021 | 34540583 | PubTator, text mining | PubMed |
| Insm1, Neurod1, and Pax6 promote murine pancreatic endocrine cell development through overlapping yet distinct RNA transcription and splicing programs. | G3 (Bethesda) | 2021 | 34534285 | PubTator, text mining | PubMed |
| PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome. | Blood Adv | 2021 | 34529761 | PubTator, text mining | PubMed |
| The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update. | J Hematol Oncol | 2021 | 34526099 | PubTator, text mining | PubMed |
| The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors. | Nat Commun | 2021 | 34518534 | PubTator, text mining | PubMed |
| Recent Development of Graphene Based Electrochemical Sensor for Detecting Hematological Malignancies-Associated Biomarkers: A Mini-Review. | Front Chem | 2021 | 34513800 | PubTator, text mining | PubMed |
| The modulatory properties of Astragalus membranaceus treatment on endometrial cancer: an integrated pharmacological method. | PeerJ | 2021 | 34513331 | PubTator, text mining | PubMed |
| Higher-risk myelodysplastic syndrome in an elderly patient: Long-term partial remission with low-dose prednisone, G-CSF, and epoetin alfa. | Clin Case Rep | 2021 | 34512981 | PubTator, text mining | PubMed |
| Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition. | Blood Adv | 2021 | 34507353 | PubTator, text mining | PubMed |
| Emerging Role of Chimeric RNAs in Cell Plasticity and Adaptive Evolution of Cancer Cells. | Cancers (Basel) | 2021 | 34503137 | PubTator, text mining | PubMed |
| A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML. | Int J Mol Sci | 2021 | 34502319 | PubTator, text mining | PubMed |
| Common Genetic Aberrations Associated with Metabolic Interferences in Human Type-2 Diabetes and Acute Myeloid Leukemia: A Bioinformatics Approach. | Int J Mol Sci | 2021 | 34502231 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=53